New hope for arthritis: korean study tests Filgotinib's power
NCT ID NCT06625242
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 21 times
Summary
This study tested the drug filgotinib in 118 Korean adults with rheumatoid arthritis, an autoimmune disease that causes joint pain and swelling. The main goal was to see how many patients had at least a 20% improvement in symptoms after 12 weeks of treatment. The study is complete, and results will show how well filgotinib controls the disease in this specific population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eisai site #01
Busan, South Korea
-
Eisai site #02
Gwangju, South Korea
-
Eisai site #03
Seoul, South Korea
-
Eisai site #04
Seoul, South Korea
-
Eisai site #05
Seoul, South Korea
-
Eisai site #06
Daejeon, South Korea
-
Eisai site #07
Seoul, South Korea
-
Eisai site #08
Seoul, South Korea
-
Eisai site #09
Daegu, South Korea
-
Eisai site #10
Seoul, South Korea
-
Eisai site #11
Anyang-si, South Korea
-
Eisai site #12
Daegu, South Korea
-
Eisai site #13
Incheon, South Korea
-
Eisai site #14
Seoul, South Korea
-
Eisai site #15
Guri-si, South Korea
Conditions
Explore the condition pages connected to this study.